Does the Time from Diagnostic Biopsy to Neoadjuvant Chemotherapy Affect the Rate of Pathologic Complete Response in Stages I–III Breast Cancer?
Abstract
Share and Cite
Le, D.; Eslami, M.; Li, H.; Hajjaj, O.; Chia, S.; Simmons, C. Does the Time from Diagnostic Biopsy to Neoadjuvant Chemotherapy Affect the Rate of Pathologic Complete Response in Stages I–III Breast Cancer? Curr. Oncol. 2020, 27, 265-270. https://doi.org/10.3747/co.27.5907
Le D, Eslami M, Li H, Hajjaj O, Chia S, Simmons C. Does the Time from Diagnostic Biopsy to Neoadjuvant Chemotherapy Affect the Rate of Pathologic Complete Response in Stages I–III Breast Cancer? Current Oncology. 2020; 27(3):265-270. https://doi.org/10.3747/co.27.5907
Chicago/Turabian StyleLe, D., M. Eslami, H. Li, O. Hajjaj, S. Chia, and C. Simmons. 2020. "Does the Time from Diagnostic Biopsy to Neoadjuvant Chemotherapy Affect the Rate of Pathologic Complete Response in Stages I–III Breast Cancer?" Current Oncology 27, no. 3: 265-270. https://doi.org/10.3747/co.27.5907
APA StyleLe, D., Eslami, M., Li, H., Hajjaj, O., Chia, S., & Simmons, C. (2020). Does the Time from Diagnostic Biopsy to Neoadjuvant Chemotherapy Affect the Rate of Pathologic Complete Response in Stages I–III Breast Cancer? Current Oncology, 27(3), 265-270. https://doi.org/10.3747/co.27.5907